A new study by researchers in the Department of Clinical Neuroscience, Karolinska Institutet, has identified 18 potential ...

When ocrelizumab became the first FDA-approved treatment for early forms of multiple sclerosis (MS) in 2017, it offered ...

A trial using PET scans to test the anti-inflammatory drug PIPE-791 finished enrolling healthy volunteers and patients with ...

The substance has been found in heroin, cannabis, and black market pills sold as the anti-anxiety drug diazepam ...

UC Riverside study may lead to new treatments for multiple sclerosis. Multiple sclerosis (MS) affects an estimated 2.3 ...

A new low-cost generic form of Tecfidera is available in the U.S. for people with relapsing forms of MS for a fraction of the ...

TG Therapeutics, Inc.'s BRIUMVI saw Q1 2025 revenue surge 137% YoY. Click to learn about TGTX growth, upcoming trials, and ...

The evolution of controversial new weight loss drugs is shining a spotlight on a crippling, little-understood food phenomenon ...

The leader of an MS-13 gang clique in the New York City suburbs is facing sentencing in a federal racketeering case involving ...

For her current research on a potential new drug for MS, she focused on ways to present “complex immunological mechanisms and clinical trial data in a clear, structured way”.